Immunomodulatory CD28 Peptides in the treatment of Collagen-Induced Arthritis
Mythily Srinivasan, M.D.S., Ph.D.
Ohio State University
The goals of Dr. Srinivasan’s study are to explore the therapeutic advantages of preventing and improving arthritis through treatment with a synthetic peptide. They will use a mouse model that shares many clinical features of human rheumatoid arthritis and serves as a pre-clinical testing ground for RA.